Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Universitätsprofessor/in, Klinik für Thorax- und Kardiovaskuläre Chirurgie
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 WS
-
2023 SS
-
2022 WS
-
2022 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)In: International Journal of Cancer (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatmentIn: Radiation Oncology Jg. 17 (2022) Nr. 1, 126Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatmentIn: European Journal of Cardio-Thoracic Surgery Jg. 61 (2022) Nr. 2, S. 269 - 276Online Volltext: dx.doi.org/ (Open Access)
-
Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cmIn: Lung Cancer Jg. 172 (2022) S. 108 - 116Online Volltext: dx.doi.org/ (Open Access)
-
Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial TumorsIn: Pathology & Oncology Research Jg. 27 (2021) S. 629993Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive ChemoradiotherapyIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1684 - 1691Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improveIn: European Journal of Cancer (EJC) Jg. 138 (2020) S. 156 - 168Online Volltext: dx.doi.org/
-
Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic ImportanceIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 195 (2019) Nr. Suppl. 1, S. S66 - S67
-
Effectiveness of Robotic Lobectomy—Outcome and Learning Curve in a High Volume CenterIn: The Thoracic and Cardiovascular Surgeon Jg. 67 (2019) Nr. 7, S. 573 - 577Online Volltext: dx.doi.org/
-
Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine CarcinomaIn: The Annals of Thoracic Surgery Jg. 107 (2019) Nr. 6, S. 1632 - 1638Online Volltext: dx.doi.org/ (Open Access)
-
Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)In: Lung Cancer Jg. 138 (2019) S. 19 - 26Online Volltext: dx.doi.org/
-
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447Online Volltext: dx.doi.org/
-
P1.14-21 Circulating Biomarkers in Thymic Epithelial TumorsIn: Journal of Thoracic Oncology Jg. 13 (2018) Nr. 10, S. S607Online Volltext: dx.doi.org/ (Open Access)
-
Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 StudyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 194 (2018) Nr. Suppl.1, S. S41 - S42Online Volltext: dx.doi.org/ (Open Access)
-
Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trialIn: Radiotherapy and Oncology (The Green Journal) Jg. 127 (2018) Nr. Suppl.1, S. S253 - S254Online Volltext: dx.doi.org/ (Open Access)
-
Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidenceIn: OncoTarget Jg. 8 (2017) Nr. 25, S. 41670 - 41678Online Volltext: dx.doi.org/ (Open Access)
-
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trialIn: Annals of Oncology Jg. 28 (2017) Nr. 5, S. 1084 - 1089Online Volltext: dx.doi.org/ (Open Access)
-
Is There a Role for Surgery in SCLC?In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. Suppl. 1, S. S64 - S65Online Volltext: dx.doi.org/
-
Prognostic Significance of Mean Lung Dose (MLD) in the dose-enhanced Radiochemotherapy of Local Advanced NSCLC - Analysis of ESPATU's Definitive Radiochemotherapy ArmIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 193 (2017) Nr. 1, S. 20
-
Pulmonary metastasectomy for sarcoma-Essen experienceIn: Journal of Thoracic Disease Jg. 9 (2017) S. S1278 - S1281Online Volltext: dx.doi.org/ (Open Access)
-
Resection of the tracheobronchial bifurcation with complete preservation of lung parenchymaIn: The Annals of Thoracic Surgery Jg. 104 (2017) Nr. 5, S. 1741 - 1747Online Volltext: dx.doi.org/
-
The influence of type of anesthesia, perioperative pain, and preoperative health status on chronic pain six months after thoracotomy-A prospective cohort studyIn: Pain Medicine Jg. 18 (2017) Nr. 11, S. 2208 - 2213Online Volltext: dx.doi.org/
-
A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine CarcinomasIn: The Annals of Thoracic Surgery Jg. 101 (2016) Nr. 5, S. 1909 - 1914Online Volltext: dx.doi.org/
-
An infrared spectroscopic blood test for non-small cell lung carcinoma and subtyping into pulmonary squamous cell carcinoma or adenocarcinomaIn: Biomedical Spectroscopy and Imaging Jg. 5 (2016) Nr. 2, S. 129 - 144Online Volltext: dx.doi.org/
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsIn: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805Online Volltext: dx.doi.org/
-
Short- and Mid-Term Changes in Lung Function after Bilateral Pulmonary MetastasectomyIn: The Thoracic and Cardiovascular Surgeon Jg. 64 (2016) Nr. 2, S. 139 - 145Online Volltext: dx.doi.org/
-
Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung CancerIn: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. 21, S. 2526 - 2533Online Volltext: dx.doi.org/
-
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 1, S. 85 - 93Online Volltext: dx.doi.org/ (Open Access)
-
Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyIn: Journal of Thoracic Disease Jg. 7 (2015) Nr. 3, S. 264 - 272Online Volltext: dx.doi.org/
-
Controlled-Release Oxycodone as "Gold Standard" for Postoperative Pain Therapy in Patients Undergoing Video-Assisted Thoracic Surgery or Thoracoscopy : A Retrospective Evaluation of 788 CasesIn: The Thoracic and Cardiovascular Surgeon Jg. 63 (2015) Nr. 6, S. 510 - 513Online Volltext: dx.doi.org/
-
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasIn: Lung Cancer Jg. 88 (2015) Nr. 1, S. 34 - 41Online Volltext: dx.doi.org/
-
Marker-free automated histopathological annotation of lung tumour subtypes by FTIR imagingIn: The Analyst / Royal Society of Chemistry (RSC) (Hrsg.) Jg. 140 (2015) Nr. 7, S. 2114 - 2120Online Volltext: dx.doi.org/ (Open Access)
-
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 35, S. 4194 - 4201Online Volltext: dx.doi.org/
-
Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factorsIn: BMC Cancer Jg. 15 (2015) Nr. 1, S. 363Online Volltext: dx.doi.org/ (Open Access)
-
Pulmonary manifestation of a condition resembling Kasabach–Merritt syndrome in a woman with abdominal angiomatosis associated with consumptive coagulopathy – surgical management : a case reportIn: Journal of Medical Case Reports Jg. 9 (2015) S. 107Online Volltext: dx.doi.org/ (Open Access)
-
Staging of lung cancer : the role of noninvasive, minimally invasive and invasive techniquesIn: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. 2, S. 521 - 531Online Volltext: dx.doi.org/ (Open Access)
-
Tracheaverletzungen, Insuffizienz von Bronchusstumpf/-anastomose und Rekurrensparese : Management der Komplikationen in der ThoraxchirurgieIn: Der Chirurg Jg. 86 (2015) Nr. 5, S. 410 - 418Online Volltext: dx.doi.org/
-
Einschränkung der Thrombozytenfunktion 11 Tage nach Clopidogrel-Gabe : Fallbericht eines Patienten mit Tako-Tsubo-Ereignis und PeriduralanalgesieIn: Anästhesiologie & Intensivmedizin Jg. 55 (2014) Nr. 3, S. 125 - 128
-
Extended resections for lung cancer with invasion of the chest wall, superior sulcus and spineIn: Der Onkologe Jg. 20 (2014) Nr. 10, S. 969 - 981Online Volltext: dx.doi.org/
-
Gene expression analysis of the 26S proteasome subunit PSMB4 reveals significant upregulation, different expression and association with proliferation in human pulmonary neuroendocrine tumoursIn: Journal of Cancer Jg. 5 (2014) Nr. 8, S. 646 - 654Online Volltext: dx.doi.org/ (Open Access)
-
Management of a Chest-Wall Soft-Tissue Tumor Caused by an Infection with the Larval Tapeworm Pathogen Taenia crassicepsIn: American Journal of Tropical Medicine and Hygiene Jg. 91 (2014) Nr. 3, S. 541 - 543Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Minimal incidence of chronic and neuropathic postthoracotomy pain after anteroaxillary thoracotomy with consequent systemic pain therapyIn: European Journal of Anaesthesiology EJA Jg. 31 (2014) Nr. 9, S. 508 - 511Online Volltext: dx.doi.org/
-
Modified Clagett Procedure Is Effective for Methicillin-Resistant Staphylococcus aureus Postpneumonectomy Empyema : A Case ReportIn: World Journal of Oncology Jg. 5 (2014) Nr. 4, S. 178 - 180Online Volltext: dx.doi.org/ (Open Access)
-
Neuroendocrine Tumors of the Lung : The Role of Surgery in Small Cell Lung CancerIn: Thoracic Surgery Clinics Jg. 24 (2014) Nr. 3, S. 313 - 326Online Volltext: dx.doi.org/
-
Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7510Online Volltext: dx.doi.org/
-
Resection of a Giant Neuroblastoma Misdiagnosed as Atypical Mediastinal CarcinoidIn: Journal of Thoracic Oncology Jg. 9 (2014) Nr. 1, S. 132 - 134Online Volltext: dx.doi.org/
-
Surgery of Primary Lung Cancer with Oligometastatic M1b Synchronous Single Brain Metastasis : Analysis of 37 CasesIn: The Thoracic and Cardiovascular Surgeon Jg. 62 (2014) Nr. 7, S. 612 - 615Online Volltext: dx.doi.org/
-
The impact of epidural analgesia compared to systemic opioid-based analgesia with regard to length of hospital stay and recovery of bowel function : retrospective evaluation of 1555 patients undergoing thoracotomyIn: Journal of Cardiothoracic Surgery Jg. 9 (2014) S. 175Online Volltext: dx.doi.org/ (Open Access)
-
Thoracic staging in lung cancer : prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CTIn: Journal of Nuclear Medicine (JNM) Jg. 55 (2014) Nr. 3, S. 373 - 378Online Volltext: dx.doi.org/ (Open Access)
-
Thymoma and thymic carcinoma : a multivariate analysis of prognostic factors in 220 patientsIn: Journal of Thoracic Oncology Jg. 9 (2014) Nr. 10, Suppl. 4, S. S241 - S242Online Volltext: dx.doi.org/
-
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)In: Lung Cancer Jg. 82 (2013) Nr. 1, S. 83 - 89Online Volltext: dx.doi.org/
-
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer : Markedly higher rate of pathologic complete remissions than with conventional fractionationIn: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 9, S. 2107 - 2115Online Volltext: dx.doi.org/
-
Epidural analgesia is not superior to systemic postoperative analgesia with regard to preventing chronic or neuropathic pain after thoracotomyIn: Journal of Cardiothoracic Surgery Jg. 8 (2013) Nr. 1, S. 127Online Volltext: dx.doi.org/
-
Experimental Respiratory Syncytial Virus Infection of Human Peribronchial Gland Cells In VitroIn: Ultrastructural Pathology Jg. 37 (2013) Nr. 5, S. 312 - 317Online Volltext: dx.doi.org/
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 15, S. 3076 - 3082Online Volltext: dx.doi.org/
-
Free soluble HLA-G molecules but not exosome-derived soluble HLA-G molecules are of prognostic relevance in lung cancer patientsIn: Tissue Antigens Jg. 81 (2013) Nr. 5, S. 282 - 283Online Volltext: dx.doi.org/
-
Glanduläres Papillom des rechten Hauptbronchus : Nachweis einer Exon-2-Mutation des KRAS-Gens (c.35G>A)In: Der Pathologe Jg. 34 (2013) Nr. 4, S. 338 - 342Online Volltext: dx.doi.org/
-
Midterm changes in quality of life : A prospective evaluation after open pulmonary metastasectomyIn: The Annals of Thoracic Surgery Jg. 95 (2013) Nr. 3, S. 1006 - 1011Online Volltext: dx.doi.org/
-
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine : The TREAT studyIn: Annals of Oncology Jg. 24 (2013) Nr. 4, S. 986 - 992Online Volltext: dx.doi.org/
-
Changes in Lung Function Parameters After Wedge Resections : A Prospective Evaluation of Patients Undergoing MetastasectomyIn: Chest Jg. 141 (2012) Nr. 6, S. 1482 - 1489Online Volltext: dx.doi.org/
-
Distribution pattern of metastases and their associations with survival of malignant pleural mesothelioma patients undergoing different treatment modalitiesIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 140
-
Erste Sicherheitsanalyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : Keine Signale für unerwartete Adverse Events/ToxizitätenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 188 (2012) Nr. Suppl. 1, S. 34Online Volltext: dx.doi.org/
-
Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural MesotheliomaIn: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, S. 1440 - 1448Online Volltext: dx.doi.org/ (Open Access)
-
Growth patterns of lung metastases from sarcoma : prognostic and surgical implications from histologyIn: Interactive Cardiovascular and Thoracic Surgery Jg. 15 (2012) Nr. 4, S. 612 - 617Online Volltext: dx.doi.org/
-
Improvement of histopathological Remission after neoadjuvant chemotherapy of accelerated hyperfractionation compared to conventional fractionation in locally advanced NSCLC (stage III)In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. Suppl. 1, S. 96 - 96
-
Lung segment geometry study : simulation of largest possible tumours that fit into bronchopulmonary segmentsIn: The Thoracic and Cardiovascular Surgeon Jg. 60 (2012) Nr. 2, S. 93 - 100Online Volltext: dx.doi.org/
-
Risk factors for impaired lung function after pulmonary metastasectomy : a prospective observational study of 117 casesIn: European Journal of Cardio-Thoracic Surgery Jg. 42 (2012) Nr. 2, S. e22 - e27Online Volltext: dx.doi.org/
-
Staging des Lungenkarzinoms : Welche Rolle spielt die Mediastinoskopie heute?In: Zentralblatt für Chirurgie Jg. 137 (2012) Nr. 3, S. 242 - 247Online Volltext: dx.doi.org/
-
State of the Art : Stage III NSCLCIn: Journal of Thoracic Oncology Jg. 7 (2012) Nr. Suppl. 6, S. 16
-
Who should be considered for surgery for stage III disease and why?In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 49
-
Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerIn: British Journal of Cancer (BJC) Jg. 107 (2012) Nr. 5, S. 823 - 830Online Volltext: dx.doi.org/ (Open Access)
-
10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 494
-
15-Year (very) long-term survival (VLTS) and competing risks (CR) analysis of induction (IND) chemotherapy (CTX) with three cycles cisplatin (P) / etoposide (E) followed by concurrent (CC) chemoradiation (CTX/RTX) PE/45 GY (1.5 GY BID) pkus surgery (S) = TRIMIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S.S 492 - S493
-
A new technique for complete intraluminal repair of iatrogenic posterior tracheal lacerationsIn: Interactive Cardiovascular and Thoracic Surgery Jg. 12 (2011) Nr. 1, S. 6 - 9Online Volltext: dx.doi.org/
-
Growth patterns of lung metastases from sarcomasIn: Virchows Archiv Jg. 459 (2011) Nr. 2, S. 213 - 219Online Volltext: dx.doi.org/
-
Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7042Online Volltext: dx.doi.org/
-
Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VEIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 495
-
Long-term survival (S) of induction chemotherapy (CTx) with three cycles cisplatin (cis)/paclitaxel (pac) followed by concurrent (cc) chemoradiation (CTx/RTx) cis/etoposide (eto) and 45 Gy (1.5 Gy bid) plus surgery (SURG) : Phase II results (CISTAXOL)In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7047Online Volltext: dx.doi.org/
-
Long-term survival results and prognostic factor analysis of two consecutive trimodality Phase-II trials in stage IIIA(N2) and selected stage IIIB non-small-cell lung cancer (NSCLC)In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 68 - 69
-
Prevention, diagnosis, therapy, and follow-up of lung cancer : interdisciplinary guideline of the German respiratory society and the German cancer society abridged versionIn: Pneumologie Jg. 65 (2011) Nr. 8, S. e51 - e75Online Volltext: dx.doi.org/
-
Randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed (CPx) versus cisplatin and vinorelbine (CVb) : TREATIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7002Online Volltext: dx.doi.org/
-
Safety distance in the resection of colorectal lung metastases : A prospective evaluation of satellite tumor cells with immunohistochemistryIn: Journal of Thoracic and Cardiovascular Surgery Jg. 141 (2011) Nr. 5, S. 1218 - 1222Online Volltext: dx.doi.org/ (Open Access)
-
Tracheoösophageale FistelIn: Der Chirurg Jg. 82 (2011) Nr. 2, S. 148 - 153Online Volltext: dx.doi.org/
-
A new endoscopic technique for intraluminal repair of posterior tracheal lacerationIn: The Annals of Thoracic Surgery Jg. 90 (2010) Nr. 2, S. 686 - 688Online Volltext: dx.doi.org/
-
Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trialIn: International Journal of Radiation Oncology, Biology, Physics Jg. 76 (2010) Nr. 3, S. 809 - 815Online Volltext: dx.doi.org/
-
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancerIn: The Thoracic and Cardiovascular Surgeon Jg. 139 (2010) Nr. 6, S. 1424 - 1430Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patientsIn: Human Immunology Jg. 71 (2010) Nr. 5, S. 489 - 495Online Volltext: dx.doi.org/
-
Prävention, Diagnostik, Therapie und Nachsorge des LungenkarzinomsIn: Pneumologie Jg. 64 (2010) Nr. Suppl. 2, S. e1 - e164Online Volltext: dx.doi.org/
-
Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancerIn: Oncology Jg. 73 (2008) Nr. 5-6, S. 316 - 323Online Volltext: dx.doi.org/
-
Pulmonary metastases of breast cancer : When is resection indicated?In: European Journal of Cardio-Thoracic Surgery Jg. 34 (2008) Nr. 6, S. 1228 - 1234Online Volltext: dx.doi.org/ (Open Access)
-
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumourIn: European Respiratory Journal Jg. 29 (2007) Nr. 1, S. 117 - 127Online Volltext: dx.doi.org/ (Open Access)
-
Solitary pulmonary nodule with growth and constrast enhancement at CT : Inflammatory pseudotumour as an unusual benign causeIn: British Journal of Radiology Jg. 79 (2006) Nr. 937, S. 76 - 78Online Volltext: dx.doi.org/
-
Value of ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapyIn: Clinical Cancer Research Jg. 12 (2006) Nr. 1, S. 97 - 106Online Volltext: dx.doi.org/
-
Langzeitüberleben und konkurrierende Risiken von Patienten einer randomisierten Studie zur defnitiven vs. neoadjuvanten Radiochemotherapie + Resektion mit einem nach der Induktion resektablen NSCLC im Stadium IIIIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S7 - S8Online Volltext: dx.doi.org/ (Open Access)
-
Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLCIn: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 65Online Volltext: dx.doi.org/
-
Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,In: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. S146 - S147Online Volltext: dx.doi.org/ (Open Access) -
Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 109 - 110Online Volltext: dx.doi.org/ (Open Access) -
Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 108Online Volltext: dx.doi.org/ (Open Access) -
18 F-FDG-Response als prognostischer Faktor für das progressionsfreie Überleben bei der Behandlung von lokal fortgeschrittenen, nichtkleinzelligen Lungenkarzinonem : Trimodale Therapie vs. definitive Radiochemotherapie – Monozentrische Ergebnisse
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 191 (2015) Nr. Suppl.1, S. S21 - S22Online Volltext: dx.doi.org/ -
Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 191 (2015) Nr. Suppl. 1, S. 36 - 37Online Volltext: dx.doi.org/ -
Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 191 (2015) Nr. Suppl. 1, S. 23Online Volltext: dx.doi.org/ -
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227Online Volltext: dx.doi.org/ -
Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study
56th Annual Meeting of the American Society for Radiation Oncology ; 14-17 September 2014, San Francisco, CA, USA,In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 1, Supplement, S. S146 - S147Online Volltext: dx.doi.org/ -
Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl. 1, S. 5 - 6Online Volltext: dx.doi.org/ -
Patients with epidural analgesia stay as long in hospital as patients with initial systemic pain therapy, but are dismissed with higher opioid doses : retrospective evaluation of 1555 patientsIn: European Journal of Anaesthesiology EJA Jg. 31 (2014) Nr. Suppl. 52, S. 234 - 235Online Volltext: dx.doi.org/
-
Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl 1, S. 17Online Volltext: dx.doi.org/ -
Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl. 1, S. 17Online Volltext: dx.doi.org/ -
WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3Online Volltext: dx.doi.org/ -
Akzeleriert-hyperfraktionierte Radiotherapie (RTx) mit simultaner Chemotherapie (CTx) im neoadjuvanten Konzept bei Stadium-III-Lungenkarzinom : signifikant höhere Rate pathologisch kompletter Remissionen (pCR) im Vergleich mit konventioneller Fraktionierung
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 189 (2013) Nr. Suppl. 1, S. 19Online Volltext: dx.doi.org/ -
Compliance-Analyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie – lassen sich Patienten lieber operieren?
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 189 (2013) Nr. Suppl. 1, S. 87Online Volltext: dx.doi.org/ -
Accelerated Hyperfractionated Radiation Therapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer : Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated Radiochemotherapy
54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, MA, USA,In: International Journal of Radiation Oncology, Biology, Physics Jg. 84 (2012) Nr. 3, Supplement, S. S154Online Volltext: dx.doi.org/ -
Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S376 - S377 -
Lung volume reduction surgeryIn: Chest surgery / Dienemann, Hendrik; Hoffmann, Hans; Detterbeck, Frank C. (Hrsg.) 2015, S. 255 - 262Online Volltext: dx.doi.org/